Categories: Technology

Copyseeker Launches n8n Community Node for Automated Reverse Image Search

If you’ve ever tried to track down where your images end up online, you know it’s a nightmare. Manual searching takes forever, and you’re bound to miss stuff. That’s the problem Copyseeker set out to solve—and today, it just got a whole lot easier with the release of an official n8n community node.

The node is live on npm: https://www.npmjs.com/package/n8n-nodes-copyseeker

What’s the big deal?

n8n is one of the most popular workflow automation tools out there, and now Copyseeker users can plug reverse image search directly into their automations. No coding required. Just drag, drop, connect, and let it run.

Think about what that means in practice. A photographer can set up a workflow that checks their portfolio images every morning, flags any new matches, and sends an email if something pops up. An e-commerce brand can monitor their product photos for knockoffs on competing sites. A marketing team can track where their campaign visuals spread across the web.

All of this runs in the background without anyone lifting a finger.

Why this matters

“I built Copyseeker because I was frustrated with how hard it was to find where images show up online,” said Mantas, who runs the service. “The API was the first step. But most people don’t want to write code just to check if someone’s using their photos. The n8n node changes that—now anyone can set up automated monitoring in minutes.”

The timing makes sense. Visual content theft is everywhere, from scraped blog images to stolen product photos on shady marketplaces. Creators and businesses need better tools to stay on top of it, and manual searches just don’t cut it anymore.

What you can actually do with it

Here’s where it gets practical:

Set up a daily scan of your image library and get Slack alerts when matches appear. Log everything to a Google Sheet or Airtable for documentation. Build a workflow that checks new product images right after upload. Combine it with other n8n nodes to create something more complex—like auto-generating takedown request drafts when high-confidence matches are found.

The node takes image URLs, runs them through Copyseeker’s search, and returns match data including where the image was found, similarity scores, and page info. From there, you route it wherever you need.

Getting started

The node works with any self-hosted n8n instance or n8n Cloud (with community nodes enabled). You’ll need a Copyseeker API key from RapidAPI, and then you’re good to go.

Installation is straightforward—just search for “copyseeker” in the n8n community nodes or grab it directly from npm.

GlobeNews Wire

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

47 minutes ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

47 minutes ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

47 minutes ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

48 minutes ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

48 minutes ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

48 minutes ago